id now covid 19 assay (Abbott Laboratories)
86
Structured Review
Abbott Laboratories
id now covid 19 assay
Id Now Covid 19 Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/id+now+covid-19/19+assay+covid+id+now/10__1016_slash_j__nexres__2025__101261-102-35-41
Average 86 stars, based on 1 article reviews
Id Now Covid 19 Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/id+now+covid-19/19+assay+covid+id+now/10__1016_slash_j__nexres__2025__101261-102-35-41
Average 86 stars, based on 1 article reviews
id now covid 19 assay - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Blocking Assay:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on CRISPR:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Extraction:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Amplification:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Polymerase Chain Reaction:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Enzyme-linked Immunosorbent Assay:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Virus:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Infection:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Real-time Polymerase Chain Reaction:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Lateral Flow Assay:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Clinical Proteomics:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Surround Optical-fiber Immunoassay:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Immunofluorescence:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Reverse Transcription:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on Multiplex Assay:Article Title: Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia Article Snippet: Article Title: Rapid deep learning-assisted predictive diagnostics for point-of-care testing Article Snippet: Target Product (corp.) method Assay time Cost Additional reader equipment Procedure COVID- 19 Ellume Rapid kit (fluoresence) <15 min 25 $ Simple BinaxNOW COVID-19 (Abbott) Rapid kit <15 min 7 $ Simple Rapid antigen test (Roche) Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease. Article Snippet: 2022, 123, 92−99. (111) Article Title: Using geographic rescue time contours, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters Article Snippet: < 30 FDA EUA https://www.fda.gov/media/136522/download , Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent pointof-care tests, i.e., Article Title: Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection Article Snippet: On day 351, SARS-CoV-2 re-infection was diagnosed by two independent point-of-care tests, i.e., Article Title: Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases Article Snippet: Article Title: ƩS COVID-19 is a rapid high throughput and sensitive one-step quadruplex real-time RT-PCR assay Article Snippet: The first group is based on RT-PCR, such as Cobas Liat SARS-CoV-2 (Roche, Switzerland) , Accula SARS-CoV-2 (Mesa Biotech, USA) , and Visby Medical COVID-19 (Visby Medical, USA) and the second group is based on |
